MGX metagenomi.co Market Valuation

Public company logo of Metagenomi, Inc (MGX)

This chart illustrates the current share price of Metagenomi, Inc. (MGX), which stands at 0.03, based on the recruitment of leading geneticists to develop AI-driven genome editing tools. Patent protection for such platforms and stringent regulatory oversight create a formidable barrier to entry for competitors. Additionally, Metagenomi, Inc. (MGX) is implementing energy-efficient technologies and emission purification systems, strictly adhering to environmental standards across its laboratories.

Metagenomi - MGX Market Capitalization (period 02/21/2024 - 11/15/2026)

Metric breakdowns and analytics for metagenomi.co (MGX)

- current price and projected stock value:
Analysis of all company metrics:metagenomi.co MGX
Product sample of Metagenomi, Inc.

Metagenomi, Inc. (MGX) maintains a strong position in genome editing thanks to a stable core of CRISPR specialists. Market capitalization determines the total business value through the product of the current quote and the number of shares outstanding. Investors view this balance as a reflection of the startup's ability to retain talent amid a shortage of geneticists. Liquidity dynamics are visualized through the company's market capitalization volume. This indicator serves as a measure of market confidence in the issuer's intellectual capital.

Competitor analysis

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Sarepta Therapeutics, Inc. - Market Capitalization|Market Capitalization TWST (twistbioscience.com)|Market Value TXG (10x Genomics Corp)|Intellia Corp - Market Capitalization|Market Capitalization Stoke Therapeutics STOK|BLFS: Market Capitalization|WVE (Wave Life Sciences) - Market Value|Market Valuation MAZE|Market Value Sionna Therapeutics, Inc. SION|Market Value Prime Medicine Bio (PRME)|Market Capitalization Taysha|uniQure Pharma - Market Valuation|Market Capitalization MeiraGTx Holdings plc MGTX|RGNX: Market Valuation|Market Value SLDB (Solid Biosciences)|OCGN (Ocugen Corp) - Market Valuation|Market Valuation Pacific Biosciences|Market Valuation BNTC|DSGN (Design Therapeutics) - Market Value|Market Capitalization RCKT|Market Value FDMT (4DMT)|Market Value Lexeo Therapeutics LXEO|Market Value KRRO|editasmedicine.com - Market Capitalization|Market Value SLN (Silence Therapeutics)|ProQR Therapeutics (PRQR) - Market Value|CDXS - Market Capitalization|SGMO (Sangamo Therapeutics Inc.) - Market Capitalization|NAUT (Nautilus Biotechnology) - Market Value|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.